<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03388957</url>
  </required_header>
  <id_info>
    <org_study_id>UDDS-Pedo-02-2017</org_study_id>
    <nct_id>NCT03388957</nct_id>
  </id_info>
  <brief_title>Oral Propranolol for Reducing Pediatric Dental Patients Anxiety</brief_title>
  <official_title>Evaluating of Oral Propranolol Effect on Managing Anxiety of Dental Extractions in Children: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Damascus University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Damascus University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluating anxiety, behavior, sedation and vital signs during dental extraction after orally
      taking either propranolol, midazolam, a combination of both or placebo in 6-9 years old
      uncooperative patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Use of 0.5 mg/kg propranolol and a combination of propranolol and midazolam for the first
      time to manage 6-9 years old uncooperative pediatric dental patients anxiety, comparing with
      midazolam and placebo by evaluating anxiety, behavior, sedation and vital signs before,
      during and after treatment.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 30, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Four groups, with 20 children in each group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Anxiety-1 levels</measure>
    <time_frame>(1) five minutes before medication, (2) 30 minutes post-extraction</time_frame>
    <description>Anxiety-1 levels will be evaluated using self-reported faces anxiety scale (also called 'modified child dental anxiety scale). Scale name: Modified Child Dental Anxiety Scale (MCDAS):
Relaxed/Not worried. (Better outcome)
Very slightly worried.
Fairly worried.
Worried a lot.
Very worried. (Worse outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Anxiety-2 levels</measure>
    <time_frame>(1) 45 minutes after medication, while applying local anesthesia, (2) after 10 minutes of applying the anesthesia and during tooth extraction.</time_frame>
    <description>Anxiety-2 levels will be measured using Observational Venham Anxiety Scale
Major Issues: 1) Will be measured in 2 phases:
45 minutes after medication, while applying local anesthesia.
While extracting the tooth. &quot;Venham Anxiety Scale&quot;: 0. Relaxed. (Better outcome)
Uneasy.
Tense.
Reluctant.
Interference.
Out of contact. (Worse outcome)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Behavior</measure>
    <time_frame>(1) 5 minutes before medication, (2) 45 minutes after medication, while applying local anesthesia, (3) after 10 minutes of applying the anesthesia and during tooth extraction, (4) 30 minutes following extraction</time_frame>
    <description>using Observational Frankl Scale &quot;Frankl Scale&quot;:
Definitely negative. (Worse outcome)
Negative.
Positive.
Definitely positive. (Better outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Sedation status</measure>
    <time_frame>(1) 5 minutes before medication, (2) 45 minutes after medication, while applying local anesthesia, (3) after 10 minutes of applying the anesthesia and during tooth extraction, (4) 30 minutes following extraction</time_frame>
    <description>using &quot;University of Michigan Sedation Scale (UMSS)&quot;: 0. Awake and alert.
Minimally sedated.
Moderately sedated.
Deeply sedated.
Unarousable. (Increasing score with high sedation level)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pulse rate</measure>
    <time_frame>(1) 5 minutes before medication, (2) 45 minutes after medication, while applying local anesthesia, (3) after 10 minutes of applying the anesthesia and during tooth extraction, (4) 30 minutes following extraction</time_frame>
    <description>using Finger Pulse Oximeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Oxygen Saturation</measure>
    <time_frame>(1) 5 minutes before medication, (2) 45 minutes after medication, while applying local anesthesia, (3) after 10 minutes of applying the anesthesia and during tooth extraction, (4) 30 minutes following extraction</time_frame>
    <description>using Finger Pulse Oximeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Blood Pressure</measure>
    <time_frame>(1) 5 minutes before medication, (2) 45 minutes after medication, while applying local anesthesia, (3) after 10 minutes of applying the anesthesia and during tooth extraction, (4) 30 minutes following extraction</time_frame>
    <description>using Wrist Automatic Digital Blood Pressure Monitor</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Extrusion of Tooth</condition>
  <arm_group>
    <arm_group_label>Propranolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be given Propranolol 0.5 mg/Kg orally.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be given Midazolam 0.5 mg/Kg orally.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propranolol and Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be given Propranolol and Midazolam with a dose of 0.5 mg/Kg orally for each drug.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>A placebo drug will be given in this group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propranolol</intervention_name>
    <description>This drug will be given before the extraction procedure</description>
    <arm_group_label>Propranolol</arm_group_label>
    <arm_group_label>Propranolol and Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>This drug will be given before the extraction procedure</description>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_label>Propranolol and Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  High to extreme fear of tooth or molar anesthesia and removal (Frankl: Negative).

          -  Scoring more than 19 points on MCDAS(f).

          -  6-9 years old healthy pediatric patients (ASA I).

          -  Indication for primary tooth or molar extraction.

          -  Fasting if indicated (severe gag reflex).

          -  Airway assessment (Mallampati and tonsillar hypertrophy).

        Exclusion Criteria:

          -  Asthma or other obstructive pulmonary disease.

          -  Cardiac failure.

          -  Cardiac arrhythmia.

          -  Renal failure.

          -  Insulin-dependent diabetes mellitus.

          -  Current use of another ÃŸ-adrenoreceptor antagonist.

          -  Current use of anxiolytic or antidepressant medication.

          -  Currently in psychotherapy for dental anxiety.

          -  Systolic blood pressure &lt;10 mmHg.

          -  Diastolic blood pressure &lt;6 mmHg.

          -  Extreme obesity (BMI).

          -  Active Upper respiratory infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>9 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar Abu Bakr, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>MSc student in Pedodontics, University of Damascus Dental School, Damascus, Syria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Altinawi, DDS MSc PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Professor of Pedodontics, University of Damascus Dental School, Damascus, SYRIA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Youssef Latifeh, MD MSc Phd</last_name>
    <role>Study Director</role>
    <affiliation>Professor and Head of the Psychiatry Department, Damascus Univesrity, Damascus, Syria</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omar Abu Bakr, DDS</last_name>
    <phone>00963933050639</phone>
    <email>omarabubakr2009@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mohamed Altinawi, DDS MSc PhD</last_name>
    <phone>00963955358197</phone>
    <email>mohamedaltinawi@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Peadodontics, University of Damascus Dental School</name>
      <address>
        <city>Damascus</city>
        <zip>DM20AM18</zip>
        <country>Syrian Arab Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed Altinawi, DDS MSc PhD</last_name>
      <phone>00963955358197</phone>
      <email>mohamedaltinawi@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Omar Abu Bakr, DDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Syrian Arab Republic</country>
  </location_countries>
  <reference>
    <citation>CotÃ© CJ, Wilson S; AMERICAN ACADEMY OF PEDIATRICS; AMERICAN ACADEMY OF PEDIATRIC DENTISTRY. Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures: Update 2016. Pediatrics. 2016 Jul;138(1). pii: e20161212. doi: 10.1542/peds.2016-1212.</citation>
    <PMID>27354454</PMID>
  </reference>
  <reference>
    <citation>Gazal G, Fareed WM, Zafar MS, Al-Samadani KH. Pain and anxiety management for pediatric dental procedures using various combinations of sedative drugs: A review. Saudi Pharm J. 2016 Jul;24(4):379-85. doi: 10.1016/j.jsps.2014.04.004. Epub 2014 Apr 26. Review.</citation>
    <PMID>27330369</PMID>
  </reference>
  <reference>
    <citation>Heaton LJ, McNeil DW, Milgrom P. Propranolol and D-cycloserine as adjunctive medications in reducing dental fear in sedation practice. SAAD Dig. 2010 Jan;26:27-35. Review.</citation>
    <PMID>20151608</PMID>
  </reference>
  <reference>
    <citation>LeCompte MT, Rae L, Kahn SA. A survey of the use of propranolol in burn centers: Who, what, when, why. Burns. 2017 Feb;43(1):121-126. doi: 10.1016/j.burns.2016.07.007. Epub 2016 Aug 27.</citation>
    <PMID>27575676</PMID>
  </reference>
  <reference>
    <citation>Steenen SA, van Wijk AJ, van der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A. Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. J Psychopharmacol. 2016 Feb;30(2):128-39. doi: 10.1177/0269881115612236. Epub 2015 Oct 20. Review.</citation>
    <PMID>26487439</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2017</study_first_submitted>
  <study_first_submitted_qc>December 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2018</study_first_posted>
  <last_update_submitted>December 31, 2017</last_update_submitted>
  <last_update_submitted_qc>December 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Propranolol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

